Ashwagandha KSM-66 and Cortisol: What Research Shows

What chronic stress does to your body

Stress is a normal biological response. The problem arises when the stress response stays activated — when cortisol levels remain elevated day after day without adequate recovery. Research has associated chronically elevated cortisol with disrupted sleep, changes in energy levels, appetite fluctuations, and reduced cognitive performance.

For many people, the cycle is self-reinforcing: stress impairs sleep, poor sleep reduces resilience to stress, which elevates cortisol further. Finding ways to support the body's natural stress regulation is therefore relevant not just for mental wellbeing but for physical health broadly.

What is ashwagandha KSM-66?

Ashwagandha (Withania somnifera) is a root used in traditional Ayurvedic medicine. KSM-66 is a full-spectrum root extract standardised to a minimum of 5% withanolides — the primary bioactive compounds. It is the most extensively clinically studied ashwagandha extract available, with over 22 randomised controlled trials published in peer-reviewed journals.

The standardisation to a consistent withanolide content is important: it means clinical trial results are more reliably applicable to the product, unlike unstandardised ashwagandha powders where bioactive content can vary significantly between batches.

What the research shows

A 2025 meta-analysis published in BJPsych Open (Bachour et al., PMC12242034) synthesised 15 randomised controlled trials on ashwagandha for stress and anxiety in adults. The analysis found statistically significant reductions in cortisol levels, perceived stress scores, and anxiety measures across all included studies.

A 2024 randomised double-blind trial (Leonard et al., Nutrients, PMC11207027) tested liposomal ashwagandha at 225mg — significantly lower than typical non-liposomal doses. The study found improvements in memory, attention, executive function, and reductions in perceived fatigue and tension. The use of liposomal delivery allowed a lower dose to achieve meaningful outcomes, consistent with enhanced bioavailability.

Research suggests ashwagandha's effects on cortisol are not immediate — studies typically show meaningful results after 4-8 weeks of consistent use. It is not a fast-acting anxiolytic but rather a compound that appears to support the body's stress adaptation over time.

Important context

Ashwagandha has no EFSA-authorised health claim under EU Regulation 1924/2006. The research above reflects independent scientific investigation, not regulatory approval. If you are experiencing significant anxiety or stress-related health issues, please consult a qualified healthcare professional.

Ashwagandha is not recommended during pregnancy. If you take thyroid medication or immunosuppressants, discuss use with your doctor before starting.

The liposomal difference

The 2024 Leonard et al. trial used a liposomal ashwagandha formulation at 225mg and achieved meaningful results — a dose considerably lower than the 600mg typically used in non-liposomal trials. This is consistent with liposomal delivery improving the bioavailability of the active withanolide compounds, allowing lower doses to achieve comparable effects.

The PPH formula

The PPH GABA + Ashwagandha KSM-66 formula contains 100mg of KSM-66 ashwagandha extract per capsule alongside GABA, L-theanine, chamomile, lemon balm, Montmorency cherry, and methylfolate — a comprehensive sleep and stress support formula designed around GABAergic calming and cortisol regulation.

Ashwagandha KSM-66 100mg — standardised to minimum 5% withanolides
GABA 250mg — the brain's primary inhibitory neurotransmitter
L-theanine 50mg — promotes alpha brainwave activity
Chamomile 100mg, Lemon balm 50mg — traditional calming botanicals
Montmorency cherry 70mg — natural source of melatonin precursors
Folate 400mcg — as 5-methylfolate, the active form

Conclusion and next step

Research suggests ashwagandha KSM-66 may support the body's cortisol regulation and reduce perceived stress over consistent use of 4-8 weeks. It works best as part of a broader approach to stress management that includes sleep, movement, and addressing the sources of stress where possible.

Explore PPH GABA + Ashwagandha KSM-66 here.

Your vitality is not optional — it is vital.

Frequently asked questions

Most studies report meaningful effects after 4-8 weeks of daily use. Do not judge the effect after one or two weeks — the cortisol-modulating effects build gradually.

Generally yes. The PPH formula combines KSM-66 with GABA and L-theanine for synergistic sleep and stress support. If you take thyroid medication, antidepressants, or immunosuppressants, consult your doctor first.

KSM-66 has been studied in trials up to 12 weeks with a good safety profile. Long-term use is generally considered safe in healthy adults. Rare reports of liver enzyme elevation exist in the broader ashwagandha literature, almost exclusively associated with very high doses or adulterated products.

KSM-66 is a full-spectrum root extract standardised to minimum 5% withanolides. Standard ashwagandha powders vary widely in withanolide content and clinical applicability. The standardisation means KSM-66 trial results are more reliably applicable to the supplement than unstandardised extracts.

Sources

Bachour G. et al. (2025). Effects of Ashwagandha on Cortisol, Stress, and Anxiety: Meta-Analysis of 15 RCTs. BJPsych Open. DOI: 10.1192/bjo.2025.10136. PubMed PMC12242034
Leonard M. et al. (2024). Acute and Repeated Liposomal Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood. Nutrients, 16(12), 1813. DOI: 10.3390/nu16121813. PubMed PMC11207027
Pratte M.A. et al. (2014). An Alternative Treatment for Anxiety: A Systematic Review for Ashwagandha. Journal of Alternative and Complementary Medicine. pubmed.ncbi.nlm.nih.gov/25211657/